Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Cimzia vs. Hadlima

Reviewed on 8/16/2019

Are Cimzia and Hadlima the Same Thing?

Cimzia (certolizumab pegol) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers used to treat Crohn's disease (CD).

Hadlima is also used to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), ulcerative colitis (UC), and plaque psoriasis (Ps).

Hadlima is biosimilar to Humira (adalimumab).

Side effects of Cimzia and Hadlima that are similar include headache, infections (e.g. upper respiratory tract, sinusitis), injection site reactions (redness, itching, bleeding, pain, and swelling), and rash.

Side effects of Cimzia that are different from Hadlima include stuffy nose, sinus pain, stomach pain, diarrhea, constipation, and urinary tract infections (UTIs).

Both Hadlima and Cimzia may interact with abatacept, anakinra, and live vaccines.

Cimzia may also interact with natalizumab, rituximab, nonsteroidal anti-inflammatory drugs (NSAIDs), and other drugs that weaken your immune system (such as cancer medicine, methotrexate, or steroids).

Hadlima may also interact with warfarin, cyclosporine, and theophylline.

What Are Possible Side Effects of Cimzia?

Side effects of Cimzia include:

  • stuffy nose,
  • sinus pain,
  • stomach pain,
  • diarrhea,
  • constipation,
  • injection site reactions (pain, redness, itching, swelling, or bleeding),
  • upper respiratory infections (flu, cold),
  • rash, and
  • urinary tract infections.

Serious side effects of Cimzia include:

Tell your doctor if you develop signs of infection while using Cimzia, such as fever, chills, persistent sore throat, persistent cough, night sweats, trouble breathing, painful/frequent urination, unusual vaginal discharge, or white patches in the mouth (oral thrush).

What Are Possible Side Effects of Hadlima?

Common side effects of Hadlima include:

  • infections (e.g. upper respiratory tract, sinusitis),
  • injection site reactions (redness, itching, bleeding, pain, and swelling),
  • headache, and
  • rash

QUESTION

What is Crohn's disease? See Answer

What Is Cimzia?

Cimzia (certolizumab pegol) is a TFN blocker indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease.

What Is Hadlima?

Hadlima (adalimumab-bwwd) is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid Arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps). Hadlima is biosimilar to Humira (adalimumab).

What Drugs Interact With Cimzia?

Cimzia may interact with abatacept, anakinra, natalizumab, rituximab, nonsteroidal anti-inflammatory drugs (NSAIDs), or other drugs that weaken your immune system (such as cancer medicine, methotrexate, or steroids). Tell your doctor if you are pregnant or plan to become pregnant during treatment with Cimzia; it is not expected to be harmful to a fetus. It is unknown if Cimzia passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.

What Drugs Interact With Hadlima?

Hadlima may interact with abatacept, anakinra, warfarin, cyclosporine, theophylline, and live vaccines.

SLIDESHOW

Inflammatory Bowel Disease (IBD) Causes, Symptoms, Treatment See Slideshow

How Should Cimzia Be Taken?

Cimzia is given by injection under the skin, in the stomach or thigh area, as directed by your doctor. Follow your doctor's directions and the schedule for your doses very carefully.

How Should Hadlima Be Taken?

The recommended dose of Hadlima for adult patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) is 40 mg every other week. Pediatric dosage is determined by the child's weight. Dosing for other conditions varies.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
SOURCE:

UCB. Cimzia Product Monograph.

http://www.cimzia.com

FDA. Hadlima Product Information.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf

Health Solutions From Our Sponsors